-
Histogen Announces Start of Hair Regrowth Clinical Evaluation
Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the start of the Company's first human clinical evaluation of ReGenica for hair regrowth. ReGenica is the first naturally stabilized and bioactive formulation of wnt proteins and natural cofactors, which are thought to act in the formation of new hair follicles. (PRWeb Nov 20, 2008) Read the full story at http://www.prweb.com/releases/Histogen/HairStudy/prweb1643564.htm
-
James W. Lintott Named Outstanding Fundraising Volunteer Of The Year
Chairman of the Children's Hospital Foundation Board recognized at National Capital Philanthropy Day Awards (PRWeb Nov 20, 2008) Read the full story at http://www.prweb.com/releases/2008/11/prweb1644124.htm
-
InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
Stem cell culture innovator asks the regenerative medicine community: "Are Your Cells Free?" Learn more about InVitria at TERMIS North America 2008, Dec. 7-10 in San Diego, CA. (PRWeb Nov 19, 2008) Read the full story at http://www.prweb.com/releases/TERMIS/BEFREE/prweb1637864.htm
-
Trusted LASIK Surgeons Welcomes LASIK Expert Michael Raizman of Boston to its Unique LASIK Directory
Trusted LASIK Surgeons launched its revolutionary Trusted LASIK S'urgeons directory service and website at www.TrustedLASIKSurgeons.com in order to provide a resource for consumers seeking to improve their vision. What sets the Trusted LASIK Surgeons directory apart is a unique screening process ensuring that only those who are among the best in LASIK Eye Surgery, Laser Surgeons in the United States are listed. Refractive eye surgeons, such as Dr. Michael Raizman, are screened based on their experience, research, publications, lectures and patient care standards. Trusted LASIK Surgeons believes Doctor Raizmans experience, research, teaching, and other professional accomplishments place him among the top 1% of LASIK surgeons in the United States. Dr. Raizman's refractive practice at Ophthalmic Consultants of Boston serves the greater Boston area with offices in Boston and Waltham. (PRWeb Nov 19, 2008) Read the full story at http://www.prweb.com/releases/boston-lasik-eye-surgery/dr-michael-raizman/prweb1591844.htm
-
Grekos Reports Successful Treatment of Heart Disease, Vascular Disease, Using Patients' Own Adult Stem Cells : Clinical Results of Adult Stem Cell Therapy for Heart Disease, Vascular Disease Presented at International Regenerative Biomedical Technology Conference
In a report unprecedented in the healthcare industry, Zannos Grekos, MD presented clinical data this week to the Dubai Congress on Regenerative Biomedical Technologies demonstrating the successful treatment of end-stage heart disease and vascular disease using Autologous Adult Stem Cell Therapy. Dr. Grekos offered cardiac nuclear scans, PET scans, and echocardiographs performed at six months and one year post-treatment, which confirm the regeneration of damaged heart tissue, the existence of new blood vessels and a dramatic improvement in heart function in patients treated with adult stem cells extracted from their own blood. (PRWeb Nov 19, 2008) Read the full story at http://www.prweb.com/releases/stem_cell/adult_stem/prweb1643054.htm
-
Faulty Study Targets Vitamins C and E
Finding of No Cardiovascular Protection Was Predictable (PRWeb Nov 18, 2008) Read the full story at http://www.prweb.com/releases/2008/11/prweb1635644.htm
-
M2S, Inc. Achieves Milestone with 150,000th Radiographic Scan for Evaluation and Surveillance of Aortic Aneurysms
M2S Inc., an industry leader in endovascular treatment planning and patient registries, announced today that the company has reached a new milestone, having processed over 150,000 radiographic scans for evaluation and surveillance of aortic aneurysms. With each scan received, M2S evaluates approximately 1,000 images, pushing M2S' total images received and processed to over 150 million. (PRWeb Nov 18, 2008) Read the full story at http://www.prweb.com/releases/endovascular/imaging/prweb1631214.htm
-
New Evidence Found for CRP as an Independent Marker for Heart Disease, Stroke
A new study published in the New England Journal of Medicine lends further importance to the screening of C-reactive protein (CRP) in the detection of heart disease and stroke risk. Life Line Screening provides CRP screening along with glucose and cholesterol screenings. (PRWeb Nov 17, 2008) Read the full story at http://www.prweb.com/releases/CRP-study/CRP-screening/prweb1618124.htm
-
Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases
Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported positive additional interim results from its ongoing phase I/II clinical study of its therapeutic DNA vaccine against hepatitis C virus (HCV). This vaccine is being delivered using Inovio’s electroporation-based DNA delivery system. In the third and highest dose cohort of the study, two of three subjects demonstrated reductions in viral load of 93% and 99.7%. Previously reported middle dose cohort results demonstrated an 87% and 98% reduction in HCV in two of three subjects, while no anti-viral effect was observed in the low dose cohort. No safety issues have been noted to date in the trial. These data suggest a potential dose response of the vaccine and support the inclusion of three additional subjects in the high dose cohort. (PRWeb Nov 17, 2008) Read the full story at http://www.prweb.com/releases/dna_vaccine/inovio_biomedical/prweb1627194.htm
-
Dr. Blair Keagy Launches MPAnalytics, Inc. Medical Consultant Group : MPAnalytics, a Medical Consultant Group, Provides Market Analysis and Guidance for New Medical Devices, Technology, and Clinical Trial Protocol
Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses evaluate the commercial potential of new medical products and technologies. (PRWeb Nov 17, 2008) Read the full story at http://www.prweb.com/releases/medical_consultant/blair_keagy/prweb1627584.htm
|
